Stockscreener 앱 받기
10.27
1.78%
0.18
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Bank of Montreal Can - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting - Business Wire
Learn to Evaluate (NEO) using the Charts - news.stocktradersdaily.com
Deep Dive Into NeoGenomics Stock: Analyst Perspectives (5 Ratings) - Benzinga
BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating - marketscreener.com
Former AstraZeneca exec takes over as CEO of $660M Fort Myers lab firm - Business Observer
Form DEF 14A NEOGENOMICS INC For: Dec 31 - StreetInsider
SEC Form DEF 14A filed by NeoGenomics Inc. - Quantisnow
NeoGenomics (NASDAQ:NEO investor five-year losses grow to 68% as the stock sheds US$85m this past week - simplywall.st
NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 - BioSpace
NeoGenomics acquires Pathline - Medical Buyer
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
NeoGenomics expands with Pathline acquisition in Northeast US - Investing.com Australia
NeoGenomics expands with Pathline acquisition in Northeast US By Investing.com - Investing.com South Africa
NeoGenomics completes acquisition of Pathline - Gulfshore Business
NeoGenomics Completes Acquisition of Pathline - BioSpace
NeoGenomics Closes Pathline Acquisition - MarketScreener
NeoGenomics (NEO) Completes Acquisition of Pathline - StreetInsider
NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019 - ACCESS Newswire
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore - ACCESS Newswire
NeoGenomics stock hits 52-week low at $8.9 amid challenges By Investing.com - Investing.com South Africa
NeoGenomics stock hits 52-week low at $8.9 amid challenges - Investing.com
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) - Yahoo Finance
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes - ACCESS Newswire
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019 - ACCESS Newswire
NeoGenomics announces CEO transition - MSN
New CEO assumes role at NeoGenomics - Gulfshore Business
(NEO) Trading Report - news.stocktradersdaily.com
NeoGenomics appoints Tony Zook as CEO - Investing.com
NeoGenomics, Inc. Announces CEO Changes - MarketScreener
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics - BioSpace
NeoGenomics appoints Tony Zook as CEO By Investing.com - Investing.com Australia
NeoGenomics Appoints Tony Zook Chief Executive - MarketScreener
NeoGenomics' New CEO Zook Takes Over as Smith Retires - MarketWatch
Tony Zook Assumes Role As Chief Executive Officer Of Neogenomics - MarketScreener
Benchmark maintains Hold on Neogenomics stock, reiterates price target By Investing.com - Investing.com Canada
Where are the Opportunities in (NEO) - news.stocktradersdaily.com
3 Reasons to Sell NEO and 1 Stock to Buy Instead - Yahoo Finance
Piper Sandler maintains Neogenomics stock with $18 target - Investing.com
Piper Sandler maintains Neogenomics stock with $18 target By Investing.com - Investing.com UK
NeoGenomics elevates Warren Stone to President and COO By Investing.com - Investing.com Australia
NeoGenomics Promotes Warren Stone to President & COO - TipRanks
Fort Myers-based NeoGenomics names new COO - Gulfshore Business
Earnings call transcript: NeoGenomics Q4 2024 results disappoint despite EPS beat - Investing.com
NeoGenomics elevates Warren Stone to President and COO - Investing.com
NeoGenomics Names Warren Stone President, COO -March 18, 2025 at 08:09 am EDT - Marketscreener.com
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer - Lelezard
0.12%
자본화:
|
볼륨(24시간):